Clear Search
·
6 Min Read

Physicians team up to treat addiction in rural areas

A distance learning model helps address substance abuse in rural and traditionally underserved areas. The program allows primary care physicians to get the input from colleagues and specialists on the call.

Behavioral Health
·
5 Min Read

Patient satisfaction surveys need to better address pain management: Fighting opioid epidemic

Medicare patient satisfaction surveys pose problems for physicians managing pain. Pressure to prescribe opioids may contribute to epidemic. Ohio takes action to change questionnaire.

Behavioral Health
·
2 Min Read

Medication-assisted treatment training to fight substance abuse

Physicians seeking to prescribe buprenorphine to fight opioid addiction must have 8 hours of certified training and obtain a waiver. Webinars offer medication-assisted treatment training.

Behavioral Health
·
4 Min Read

Survey: Physicians support PDMPs, face limits with non-opioid therapy

The AMA released survey results showing support for policies to end the opioid epidemic, including improving PDMPs, education and ending barriers to care.

Press Releases
·
5 Min Read

Medical residents battle opioid epidemic in Massachusetts

Medical residents at Boston hospitals led the way to gain access to the prescription drug monitoring program. This tool helps them reduce prescription opioid misuse and provides more informed care to their patients.

Improve GME
·
6 Min Read

Putting patient at the center of pain management: Fighting opioid crisis

When it comes to the comprehensive management for chronic pain, recognize that patients with a history of alcoholism or substance use disorder are at higher risk for abuse, and should be managed very carefully.

Behavioral Health
·
3 Min Read

New naloxone product could save thousands of lives

The Food and Drug Administration has approved a nasal spray version of naloxone—the medication that can reverse the effects of an opioid overdose and save thousands of lives by restoring breathing and preventing death. The approval marks another gain in the effort to curb the opioid overdose epidemic.

Behavioral Health
·
2 Min Read

AMA applauds FDA for approving naloxone product to prevent overdoses

The AMA praises the FDA for approving the nasal spray version of naloxone, a medication that can reverse effects of an opioid overdose by restoring breathing.

Press Releases
·
3 Min Read

As opioid use disorders increase, physicians offer solutions

As the opioid epidemic remains a devastating issue for patients and their families, a study published Tuesday in JAMA highlights the need to enhance access to treatment to curb the rising toll opioid use disorders are taking on the country.

Behavioral Health